Roivant Sciences (ROIV) Income towards Parent Company (2020 - 2024)

Roivant Sciences (ROIV) posted Income towards Parent Company of $373.2 million for Q4 2024, up 966.2% on a QoQ basis from -$43.1 million in Q3 2024, and up 264.66% year-over-year from $102.3 million in Q1 2024.

Roivant Sciences (ROIV) Income towards Parent Company (2020 - 2024) Analysis & Trends

Roivant Sciences' Income towards Parent Company history runs 5 years deep, the most recent figure standing at $373.2 million for Q4 2024.

  • Quarterly Income towards Parent Company rose 264.66% year-over-year to $373.2 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $373.2 million (up 306.6% YoY) and the FY2025 annual result came in at $373.2 million, up 218.42% from the prior year.
  • Income towards Parent Company was $373.2 million for Q4 2024 at Roivant Sciences, up from -$43.1 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $373.2 million in Q4 2024 and bottomed at -$1.1 billion in Q4 2022.
  • A 5-year average of -$216.2 million and a median of -$225.6 million in 2021 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2021 — Income towards Parent Company slumped 1167.12% — and 2024, when it surged 264.66%.
  • Roivant Sciences' Income towards Parent Company stood at -$275.6 million in 2020, then plunged by 129.61% to -$632.8 million in 2021, then sank by 66.66% to -$1.1 billion in 2022, then jumped by 78.51% to -$226.6 million in 2023, then jumped by 264.66% to $373.2 million in 2024.
  • Business Quant data shows ROIV's Income towards Parent Company at $373.2 million in Q4 2024, -$43.1 million in Q3 2024, and $89.1 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Roivant Sciences 24.16 Bn 24.16 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2024 373.19 Mn
Sep 30, 2024 -43.08 Mn
Jun 30, 2024 89.09 Mn
Dec 31, 2023 -226.64 Mn
Sep 30, 2023 -86.10 Mn
Jun 30, 2023 -327.85 Mn
Dec 31, 2022 -1.05 Bn
Sep 30, 2022 -315.92 Mn
Jun 30, 2022 -353.78 Mn
Dec 31, 2021 -632.80 Mn
Sep 30, 2021 -225.64 Mn
Jun 30, 2021 -101.08 Mn
Dec 31, 2020 -275.60 Mn
Sep 30, 2020 -53.50 Mn
Jun 30, 2020 -7.98 Mn